Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Development of Medications to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)

    NIDA plans to fund research developing interventions to prevent and treat substance use disorders and overdoses, from preclinical studies to clinical trials.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)

    This grant funds research on drug use behaviors, prevention, and health services by analyzing existing social science, behavioral, and neuroimaging data.

    HHS-NIH11Due Nov 3, 2026· 7d

    Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)

    Use existing data to analyze drug use behaviors, prevention strategies, and service utilization, aiming to advance substance use research.

    HHS-NIH11Due Nov 3, 2026· 7d

    Pilot and Feasibility Studies in Preparation for Substance Use and HIV Prevention Intervention and Services Research Trials

    This grant supports pilot studies to develop and test interventions or services for substance use and HIV prevention, requiring collaboration with stakeholders and a clear theory of change.

    HHS-NIH11Due Jul 16, 2029$450,000

    Forecast for HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)

    NIH will soon offer funding for research to develop non-addictive small molecule and biologic pain treatments, supporting projects from early optimization through Phase I trials as part of the HEAL Initiative.

    HHS-NIH11Due Feb 20, 2029$11,000,000

    Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)

    Funding for Alzheimer's drug development from pre-clinical to Phase I clinical trials to prevent, slow, or treat AD symptoms, excluding basic research and non-pharmacological interventions.

    HHS-NIH11Due Nov 5, 2026· 9d$1,500,000